2025-2026 89th Legislature
SB883
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Recorded floor votes
5 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
April 10, 2025 · Senate
Rules suspended-Regular order of business
Passed
23 yea–7 nay · 1 absent
April 10, 2025 · Senate
Passed
Passed
23 yea–7 nay · 1 absent
April 10, 2025 · Senate
Rules suspended-Regular order of business
Passed
23 yea–7 nay · 1 absent
April 10, 2025 · Senate
Read 2nd time & passed to engrossment
Passed
23 yea–7 nay · 1 absent
April 10, 2025 · Senate
Rules suspended-Regular order of business
Passed
23 yea–7 nay · 1 absent
Committee referrals
April 22, 2025 · House
Public Health
February 13, 2025 · Senate
Health & Human Services
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Referred to Public Health
-
House Read first time
-
House Received from the Senate
-
Senate Reported engrossed
-
Senate Record vote
-
Senate Passed
-
Senate Read 3rd time
-
Senate Record vote
-
Senate Rules suspended-Regular order of business
-
Senate Record vote
-
Senate Read 2nd time & passed to engrossment
-
Senate Record vote
-
Senate Rules suspended-Regular order of business
-
Senate Co-author authorized
-
Senate Placed on intent calendar
-
Senate Committee report printed and distributed
-
Senate Reported favorably w/o amendments
-
Senate Vote taken in committee
-
Senate Considered in public hearing
-
Senate Left pending in committee
-
Senate Testimony taken in committee
-
Senate Considered in public hearing
-
Senate Scheduled for public hearing on . . .
-
Senate Co-author authorized
-
Senate Referred to Health & Human Services
-
Senate Read first time
-
Senate Filed
-
Senate Received by the Secretary of the Senate